EZN-4176

· Enzon Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EZN-4176, covering 2012-12-18 to 2012-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer [Phase 1]

See pricing